Details for New Drug Application (NDA): 020398
✉ Email this page to a colleague
The generic ingredient in PROPULSID is cisapride monohydrate. There are two drug master file entries for this compound. Additional details are available on the cisapride monohydrate profile page.
Summary for 020398
Tradename: | PROPULSID |
Applicant: | Janssen Pharms |
Ingredient: | cisapride monohydrate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020398
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | EQ 1MG BASE/ML | ||||
Approval Date: | Sep 15, 1995 | TE: | RLD: | No |
Expired US Patents for NDA 020398
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Pharms | PROPULSID | cisapride monohydrate | SUSPENSION;ORAL | 020398-001 | Sep 15, 1995 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription